Welcome to our dedicated page for Mobix Labs SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Mobix Labs鈥� progress means wading through pages packed with RF engineering talk, defense export rules, and supply-chain diagrams. If finding R&D spend or a design-win update in the latest 10-K feels daunting, you鈥檙e not alone.
Stock Titan solves that problem. Our AI reads every Mobix Labs annual report 10-K simplified, Mobix Labs quarterly earnings report 10-Q filing, and Mobix Labs 8-K material events explained the moment they hit EDGAR. It extracts what professionals actually need鈥攃hip sales by end-market, defense-contract exposure, pending patents鈥攖hen writes a plain-English brief you can absorb in minutes. Want to follow Mobix Labs insider trading Form 4 transactions? AG真人官方-time alerts show executive stock moves before markets react, so you can monitor Mobix Labs executive stock transactions Form 4 without refreshing a spreadsheet.
Here鈥檚 what you鈥檒l uncover on this page:
- 10-K & 10-Q鈥擜I breakdowns of revenue by automotive, medical, and aerospace customers, plus year-over-year R&D trends.
- 8-K鈥擨nstant summaries whenever design-wins, supply-chain disruptions or leadership changes surface.
- Form 4鈥擬obix Labs Form 4 insider transactions real-time, helping you track buying before new product announcements.
- DEF 14A proxy statement executive compensation analysis outlining option grants tied to RF innovation milestones.
Whether you鈥檙e comparing quarter-over-quarter gross margin shifts or simply understanding Mobix Labs SEC documents with AI, every filing is here, already explained, and continuously updated. Save hours, gain clarity, and make informed decisions with data that matters.
Samini Keyvan, who serves as President, CFO and a director of Mobix Labs, Inc. (MOBX), reported transactions dated 05/30/2025. The filing shows a disposition of 2,868,204 shares of Class A common stock and discloses several insider awards and holdings intended as compensation and retention.
The reporting person holds or controls derivative and contingent interests including 323,529 exercisable options with a $0.17 exercise price expiring 08/10/2030, 333,333 restricted stock units that convert one-for-one and vest on 12/21/2025, and 915,033 Class B restricted stock awards granted 05/30/2025 that vest over five years. Certain shares are held indirectly through named trusts with amounts disclosed.
James J. Peterson, a director and reported >10% owner of Mobix Labs (MOBX), reported a material change in his equity holdings. On 05/30/2025 he disposed of 2,970,545 Class A common shares. The filing also shows Peterson holds vested stock options and convertible Class B shares that convert into Class A shares.
Specifically, Peterson holds 20,000 options exercisable at $4.18 (exp. 08/10/2030) and 133,416 options exercisable at $6.84 (exp. 04/04/2032), both fully vested. He also holds 1,449,275 Class B shares convertible into Class A, and received 915,033 Class B restricted stock awards (RSAs) on 05/30/2025 that vest 10% on May 30, 2026 and the remaining 90% in equal quarterly installments over the following 48 months.
Frederick C. Goerner, a director of Mobix Labs, Inc. (MOBX), reported changes to his holdings. The Form 4 shows a disposition of 1,436,525 shares of Class A common stock. He continues to hold vested derivative positions totaling 153,416 Class A equivalents via options (20,000 at a $4.18 strike; 133,416 at a $6.84 strike) exercisable through 2030 and 2032. On May 30, 2025 he received 915,033 Class B restricted stock awards that convert into Class A shares and vest over five years (10% after one year, then equal quarterly installments over 48 months). The Class B shares convert on certain transfers or automatically after the seventh anniversary of the closing date (December 21, 2023).
Summary: This 8-K/A corrects the registrant's July 29, 2025 filing to reflect the July 23, 2025 announcement that Fabian Battaglia, the Companys Chief Executive Officer and a named executive, will step down as CEO and resign from the Board, each effective July 25, 2025. Mr. Battaglia will serve as a senior advisor and consultant to the CEO and Board through December 31, 2026, will retain his previously granted equity awards, and the Company will pay for his and his spouses COBRA health benefits for 36 months. The filing lists a Retirement and Release Agreement dated July 25, 2025 as Exhibit 10.1.
On 17 Jul 2025, Sage Hill Investors, LLC and its principal, Vernon Davis Grizzard III, filed Amendment No. 3 to Schedule 13G for Mobix Labs, Inc. (MOBX). The filing, triggered by ownership as of 30 Jun 2025, discloses beneficial ownership of 3,142,857 Class A shares鈥攅qual to 6.1 % of the outstanding class (CUSIP 60743G100).
The reporting persons hold sole voting power over the entire stake but only 1,642,857 shares under sole dispositive power; no shares are subject to shared voting or dispositive power. The Schedule was filed pursuant to Rule 13d-1(c), indicating a passive investment. The certification explicitly states the securities were not acquired to influence or change control of Mobix Labs.
This size places Sage Hill/Grizzard among the issuer鈥檚 largest shareholders, potentially increasing governance visibility while avoiding control-person status. No transaction, purchase price, or intent to seek board representation is described.